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It is unclear to what degree depersonalization disorder (DPD) and alexithymia share abnormal brain
mechanisms of emotional dysregulation. We compared cerebral processing of facial expressions of
emotion in individuals with DPD to normal controls (NC). We presented happy and sad emotion
expressions in increasing intensities from neutral (0%) through mild (50%) to intense (100%) to DPD and
non-referred NC subjects in an implicit event-related fMRI design, and correlated respective brain
activations with responses on the 20-item Toronto Alexithymia Scale (TAS-20) and its three subscales F1-
F3. The TAS-20 predicts clinical diagnosis of DPD with a unique variance proportion of 38%. Differential
regression analysis was utilized to ascertain brain regions for each alexithymia subscale. Differential
regions of total alexithymia severity for happy emotion were the globus pallidus externus; for identifying
feelings (TAS-20 F1 subscale), the right anterior insula; for description of feelings (F2), the right dorsal
mid-anterior cingulate gyrus (BA 24); and for externally oriented cognitive style (F3), the left
paracingulate gyrus (BA 32). For sad emotion, the differential region for the total TAS-20 score was the
dorsal anterior cingulate gyrus (BA 24); for TAS-20 F1, the left inferior anterior insula; for TAS-20 F2, the
right PCC (BA 31); and for TAS-20 F3, the right orbital gyrus (BA 10). Supporting our hypotheses, the
ascertained brain regions for TAS-20 subscales subserve interoception, monitoring and reﬂection of
internal states and emotion. The presented analyses provide evidence that alexithymia plays a
substantial role in emotional dysregulation in DPD, presumably based on restrictions in interoception.
& 2013 Elsevier Ireland Ltd. Open access under CC BY license.1. Introduction
Alexithymia is a cognitive trait, which has been implicated in
emotion dysregulation in a number of mental, somatoform and
somatic health problems. Alexithymia is associated with reduced
introspective awareness and a lack of emotional reasoning towards
others and the self (Taylor, 1984). As a consequence, verbal
expression of emotions and cognitive reﬂection of emotional
processes is impaired, and this leads to a tendency to respond
with unmoderated physiological arousal states towards external
events (Spitzer et al., 2005). The higher autonomic reactivity
is generally seen as an adverse disposition that profoundly con-
tributes to stress-related mental and somatic disorders. A disposi-
tion towards heightened internal arousal due to increased
physiological reactivity has also been demonstrated to accompany
more extreme cognitive and moral tendencies (Oxley et al., 2008).fax: +11 44 20 7848 0379.
e).
der CC BY license.The alexithymia syndrome was introduced as a research con-
struct by the psychiatrist Sifneos in 1972 (Taylor, 1984), and later
operationalized by Taylor and colleagues as a self-report instru-
ment, the Toronto Alexithymia Scale (TAS-26 and TAS-20, with its
factor-analytic subscales F1-F3), which is at present the most
widely accepted research measure. The TAS-20 subscale F1 reﬂects
the ability to internally discriminate and identify feelings and
emotions. The TAS-20 subscale F2 consists of self-report items
quantifying the capability to cognitively represent and to verbalize
feelings and emotions. Finally, the F3 subscale of the TAS-20
contains self-descriptions endorsing the inclination to maintain
an outward direction of attention with respect to material objects.
Recent longitudinal developmental research has also yielded
evidence to support the notion that the alexithymia trait may consist
of a neurodevelopmental cognitive deﬁcit (Lemche et al., 2004), which
might explain its lifetime endurance. Moreover, overlaps have recently
been highlighted to exist between alexithymia and autism spectrum
disorders, e.g. in the lack of emotion-related cognition, incapability of
introspection, and deﬁcits in processing reﬂections on signiﬁcant
others (Fitzgerald and Molyneux, 2004). In support of this conjecture,
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observed in autism may be due to the large co-morbidity between
alexithymic traits and autism (Bird et al., 2010). As has been argued,
both developmental disorders share common impairments in self-
and other-related mentalization. Furthermore, a view according to
which alexithymia could be a neurologically driven process has
recently received strong support by the replicated neuropsychological
ﬁnding that alexithymia appears regularly as a consequence of
traumatic brain injury (Wood and Williams, 2007; Wood et al.,
2009). As is well documented, alexithymia is typically found con-
comitant to somatization states, depression, anxiety, cardiovascular
problems and affective disorders in large population samples (Wood
et al., 2009).
Emotional dysregulation is also a key feature in DPD, a
syndrome often subsumed under dissociation (Sierra, 2010).
Typical co-morbidities of DPD include anxiety and depression
(Mula et al., 2007; Baune et al., 2010), whereas dissociative
memory impairments are not regularly found when depersonali-
zation/derealization diagnoses are present (Baker et al., 2003).
Most recent studies on DPD have revealed altered social compe-
tence based on fewer self-reported cognitive empathic abilities
(Lawrence et al., 2007). The empathy deﬁcits were found to
include social anxieties alongside an increased self-orientation
bias, which is reminiscent of ﬁndings in alexithymia. There are
bidirectional ﬁndings in DPD regarding possible emotional mem-
ory impairments. On the one hand, DPD patients showed elevated
recognition for emotive words (Montagne et al., 2007), yet lacked
the usual enhancement effect for emotional memories (Medford
et al., 2006). This behavioral deﬁcit corresponds to a lack of
activation in the relevant cerebral regions (Medford et al., 2006).
According to previous functional magnetic resonance imaging
(fMRI) studies (Phillips et al., 2001), DPD patients tend to respond
with increased right ventrolateral prefrontal cortex engagement
towards visual emotional stimuli, instead of activating limbic
regions. Recently, alexithymia level has been deemed a strong
predictor of a clinical DPD diagnosis (Simeon et al., 2009). We
therefore decided to investigate in greater detail the relationship
between alexithymia and DPD using an experimental fMRI study.
With respect to clinical alexithymia, recent ﬁndings typically
suggest a strong interrelation with dissociation with regard to
posttraumatic stress, emotional numbing, and alexithymia
(Frewen et al., 2008). In individuals with posttraumatic stress
disorder (PTSD), TAS-20 scores correlated positively with neural
responses in insula, posterior cingulate cortex (PCC), and thala-
mus, and negatively with response in anterior cingulate cortex
(ACC) (Frewen et al., 2006).
To be able to compare cerebral mechanisms of alexithymia in DPD
with normal emotional functioning, we used an emotional facial
expression paradigmwith fast implicit visual stimulation that resem-
bles natural social encounters. We planned to compute correlation
images to ascertain brain regions associated with the TAS-20 and its
subscales. Differential regression was used to identify brain regions
that differ in association with questionnaire scores, which would
enable us to compare both groups with respect to differential
substrates of alexithymia traits. We expected to be able to ﬁnd
alexithymia correlations in the above regions. In particular, for normal
controls, we hypothesized correlations in the (i) paracingulate/ante-
rior and posterior cingulate regions previously (ii) implicated in
healthy controls (Berthoz et al., 2002). For DPD patients, we expected
(iii) correlations in the insula, (iv) the thalamus, (v) and further
regions in the pain matrix, as reported for alexithymia in clinical
populations (Kano et al., 2007). For the subscales F1 and F2,
speciﬁcally, we expected to ﬁnd regions with interoceptive accuracy
discriminating the two groups, following respective ﬁndings in
normal individuals (Critchley et al., 2004): (vi) anterior insula,
thalamus, operculum, and anterior cingulate. For simple correlationsof subscales F1 and F2, however, we anticipated for DPD patients
regions not associated with emotional awareness (vii).2. Experimental procedures
2.1. Participants
The Joint South London Maudsley and Institute of Psychiatry Research Ethics
Committee endorsed all experimental procedures. The study was conducted in
compliance with the Helsinki Declaration (World Medical Association, 1991), and
normal controls (NCs) were compensated for their participation. Informed consent
was signed by all subjects to the scientiﬁc use of their data. Investigated was a total
sample of 21 volunteers. The nine primary-diagnosis DPD patients (mean age,
36.1177.31 SD years; education level, 2.2270.68; 2¼ junior college level) con-
sisted of ﬁve males and four females. These patients were in treatment for DPD at
the Maudsley Hospital, London, in a specialized clinic (ASD and MLP). A psychiatrist
not involved in the study had independently diagnosed DPD according to DSM-IV-
TR (300.6) criteria, and the clinical cut-off level of 470 on the Cambridge
Depersonalization Scale (CDS) discriminative for DPD (Sierra and Berrios, 2000)
was exceeded for all patients (mean score 175.777110.85). Patients were unme-
dicated in majority, but three of them were medicated, each with different
substances (paroxetine, ﬂuoxetine, olanzapine). Minor co-morbid dysthymic
(DSM-IV-TR 300.4) and/or mild inspeciﬁc anxiety symptoms (DSM-IV-TR 300.02)
were diagnosed in six patients. The DPD patients were compared to 12 normal
control (NC) subjects chosen to match education, socioeconomic status, gender
ratio, and general intellectual and social functioning (mean age, 27.2574.95 years;
education level, 2.5870.79; 7 males and 5 females). All participants were right-
handers according to scores on the Edinburgh Handedness Inventory (Oldﬁeld,
1971).
2.2. Self-report questionnaire data
Clinical self-report forms were completed prior to MRI scans. All participants
completed the Toronto Alexithymia Scale, 20-item version (Taylor et al., 1988,
1990), further to the CDS clinical cutoff measure for DPD (see above). The TAS
factors are replicable across cultures, with well-established psychometric proper-
ties, and are a widely accepted measure of the alexithymia construct. As described
above, the three subscales of the TAS, F1–F3, quantify identiﬁcation feelings and
emotions (F1), description of feelings and emotions (F2), and orientation to
external objects (F3). A sample statement for F1 items is: “When excited, I don't
know if I am sad, anxious or angry”. An example of F2 statements is: “Others ask me
to better explain my feelings”. A representative statement in F3 is: “I like to share
my opinion on things”.
2.3. Implicit facial expression neuroimaging tasks
Subjects were presented with 20 facial expression stimuli at 0% (neutral)–50%
(mild)–100% (intense) intensities of happy and sad emotion expressions. Separate
scans were performed for happy and sad conditions. Subjects were required to
determine the sex of the face in the implicit emotion recognition task. The exact
paradigm is described in Appendix A linked to this article. The percentage of
correct responses had been found to be the most accurate index in group
comparisons with regard to type I error rates, statistical power and sensitivity for
our ranges of experimental trial numbers (Rotello et al., 2008).
2.4. fMR image acquisition and analysis
Gradient echo echoplanar imaging (EPI) data were acquired on a Neurovascular
GE Signa 1.5 T system (General Electric, Milwaukee, WI, USA.), equipped with 40 m/
mT high-speed gradients at the Maudsley Hospital, London, UK. A quadrature
birdcage headcoil was used for RF transmission and reception. 180 T2n-weighted
images were acquired over 6 min for each of the two tasks at each of 16 near-axial
noncontiguous 7-mm-thick planes parallel to the intercommissural (anterior
commissure-posterior commissure, AC-PC) line: TE 40 ms, TR 2000 ms, in-plane
resolution 3.44 mm, interslice gap 0.7 mm, ﬂip angle (FA) α 701, matrix 642, ﬁeld of
view (FOV) 25 cm providing whole brain coverage. During the same session, a high-
resolution EPI dataset was acquired with a gradient echo EPI pulse sequence. The
structural images were acquired at 43 near-axial 3-mm-thick planes parallel to the
AC-PC line: TE 73 ms, TI 180 ms, TR 16,000 ms, in-plane resolution 1.72 mm, inter-
slice gap 0.3 mm, matrix size 1282, FOV 25 cm, FA α 901. The high resolution EPI
dataset was later used to register the fMRI datasets acquired from each individual
in standard stereotaxic space. The statistical software program package XBAM
(www.brainmap.it) developed at the Institute of Psychiatry, was used to perform
the analysis of the fMRI data. XBAM combines nonparametric permutation based
resampling methods with GLM statistics, wavelet signal denoising methods, control
of false-positive voxels and clusters, and reports exact signiﬁcances rather than
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analysis methods can be found in Appendix A linked to this article.2.5. Correlation images
Under the assumption that the subtraction map reﬂects pure emotion-induced
cerebral activation at higher intensity levels, 100–50% aggregate images were
computed, after removing neutral facial expression activation. The aggregate
images were used as a basis for correlation analysis with TAS-20 scales. The
method herein used was ﬁrst to compute the Pearson product-moment correlation
coefﬁcient r between the measured TAS-20 factor scales and blood oxygen level-
dependent (BOLD) effect data, and then to compute the null distribution of
correlation coefﬁcients by permuting the BOLD data at each voxel a minimum of
50 times, and combining the data over all voxels. Age and sex were entered into all
correlations as covariates. Threshold cluster level maps, where r is signiﬁcant, could
then be computed at the expected level of type I error clusters as previously
described. Comparative peak signal levels (for the two groups) of BOLD signal
changes in these regions were determined by extracting the effect sizes of the peak
active voxels for each of the two groups.Table 1
Comparisons of control vs. depersonalization patient groups—alexithymia
self-report data.
Alexithymia and
composites
Control Depersonalization Median
test
p-
Value
M SD M SD
TAS-20 Mean Score 36.66 12.48 52.44 12.62 −2.85 0.010
TAS-20 Factor 1 1.603 0.43 4.460 1.12 −1.91 0.071
TAS-20 Factor 2 2.431 0.97 4.028 2.89 −1.79 0.089
TAS-20 Factor 3 2.132 0.53 4.917 6.42 −1.51 ns
Note: d.f.¼19.2.6. Images of differences in regression slopes
The aggregate activation maps and correlation images served as a basis for the
ascertainment of regions in which the two groups signiﬁcantly differed for an
alexithymia factor. Differential linear regression models were set up by inclusion of
age and sex as covariates of no interest, and used 50 permutations per voxel to test
the regression slope difference between the two groups. The α-level for the 3D
cluster difference of the regression slopes was set at po0.05 voxel-wise followed
by a cluster level of 0.01. For individual measures of clinical traits, the extent of the
difference in regression of the behavioral data and individual fMRI contrasts
between two groups were computed and tested for signiﬁcance. Group differences
in regression slopes can be calculated at each voxel by ﬁrst computing, for each
group independently, the regression coefﬁcient between the behavioral clinical
data for each subject and the BOLD signal, and then by subtracting the resulting
two values. To determine the signiﬁcance of these differences in linear regression
slopes, the appropriate null distribution was generated by randomly permuting
subjects between the groups (without replacement), therefore removing group
differences. For each of the permutations, the difference in regression slopes
between the permuted groups was calculated and the resulting values were
combined over all voxels to produce a whole brain null distribution of differences
in regression.
The critical value for signiﬁcance at any particular p value was then obtained
from this distribution after simply sorting it and selecting the appropriate point
from the sorted distribution. For example, the critical value for a one-tailed test at
p¼0.05 would be the value of the difference in regression coefﬁcients in the null
distribution chosen such that 95% of all the null values lay below that point. Testing
can then be extended to cluster level as described previously. The cluster
probability under the null hypothesis can be chosen to set the level of expected
type I error clusters at an acceptable level (e.g. o1 3D cluster per whole brain).
Signal levels for the differential regions so ascertained used as masks were then
extracted at 6 s post-stimulus (the peak hemodynamic response time) using the
aggregate activation, by choosing the most activated voxel. The extraction was done
for descriptive purposes to inform about signal levels, without re-analysis of
the data.Fig. 1. Distribution of alexithymia severity.3. Results
3.1. Performance accuracy during the gender decision task
Percentage correct responses (7SD) in determination of the
sex of the faces were: 0% happy, NC 46.25712.08, DPD
48.78711.59; 50% happy, NC 60.00712.25, DPD 48.89716.54;
100% happy, NC 47.5078.66, DPD 48.3377.91; 0% sad, NC
42.0876.20, DPD 46.6778.66; 50% sad, NC 55.42710.32, DPD
58.89711.67; 100% sad, NC 57.08710.97, DPD 51.6779.01. Test-
ing for signiﬁcance, judgment accuracies in the gender decision
task for facial expressions yielded no signiﬁcant between-group
contrasts. Overall ﬁgures were in line with other studies utilizing
implicit facial paradigms (Surguladze et al., 2005). No systematic
differences between DPD and NC emerged for reaction times.3.2. Self-report questionnaires
The descriptive values for the questionnaire data are listed in
Table 1. The internal consistencies of the CDS (Cronbach's α¼0.95)
and the TAS (TAS-20 α¼0.86, F1 α¼0.91, F2 α¼0.97, F3 α¼0.87)
scales were satisfactory for subsequent analyses. Signiﬁcant between-
group differences were observed for the Toronto Alexithymia
Scale with its dimensions for Identiﬁcation of Feelings (TAS-20
F1) and Description of Feelings (TAS-20 F2), and its dimension
for External-Concrete cognitive style (TAS-20 F3). In all of these
dimensions, scores were higher for DPD patients than for NC.
These signiﬁcant group differences, however, do not imply clinical
cutoff levels. Alexithymia severity is currently classiﬁed as low
(TAS-20 score ≤ 51), moderate (51o TAS-20 score o61), or high
alexithymia levels (TAS-20 score ≥ 61) (Spitzer et al., 2005).
According to this classiﬁcation, the distributions pertaining to
the alexithymia level in NC were 83% low, 8% moderate, and 8%
high. In DPD, alexithymia levels were low 33%, moderate 44%, and
high 22%. (Fig. 1). Also according these distributions, the differ-
ences in alexithymia severity between NC and DPD were signiﬁ-
cant (Wald–Wolfowitz Z¼−3.105, exact one-tailed po0.001). In
sum, our NC group is strongly low alexithymic, whereas the
alexithymia severity in the DPD group is by two-thirds on mid-
to-high alexithymia levels, with strong clinical alexithymia sever-
ity in the upper quartile range.3.3. Interrelations of the self-report questionnaires
Age was signiﬁcantly correlated at po0.05 (two-tailed) with
total alexithymia severity (r¼0.46), but not with subscale scores,
Table 3
Comparison of regression slopes depersonalization disorder4normal control
subjects in sad expression intensities Alexithymia and composite taxons.
Region Hemisphere BA Mass X Y Z p-
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associated with any self-report. CDS correlated with TAS-20
(r¼0.55), with F1 (r¼0.54), and only marginally with F2
(r¼0.38), but not with F3.Value
TAS-20 Alexithymia level
Dorsal anterior cingulate L 24 590.4 −8 4 31 0.0087
F1 Difﬁculty identifying feelings
Anterior insula L 393.6 −39 11 9 0.0109
F2 Difﬁculty describing feelings
Posterior cingulate L 31 393.6 −4 59 31 0.0288
F3 Externally oriented thinking
Orbital gyrus R 10 492.0 −22 52 −2 0.0096
Note: Mass volume in mm3, BA Brodmann area, XYZ Talairach coordinates, p-value
tested against 50 random permutations.3.4. Prediction of clinical diagnoses
Given the behavioral results, we attempted to replicate the predic-
tion of DSM diagnoses of DPD by using clinical scales, as described in
the literature (Sierra and Berrios, 2000; Simeon et al., 2009). Logistic
regression was used to model the linear relationships between CDS
and TAS-20 and clinical diagnoses. Receiver operating characteristics
(ROC) were utilized to assess the classiﬁcation sensitivity of the self-
report scales with respect to psychiatric diagnosis. The CDS
score signiﬁcantly predicted the clinical DPD diagnosis (χ2¼17.453,
−2 log likelihood¼11.229, Wald¼5.509, Nagelkerke R2¼0.758,
po0.0001) (95% CIs 1.040–1.517). With CDS as classiﬁer, the area
under the ROC curve¼0.97, asymptotic po0.0001 (95% CIs 0.909–
1.063). In addition, also the total TAS-20 score predicted signiﬁ-
cantly DPD diagnosis (χ2¼7.076, −2 log likelihood¼21.606,
Wald¼4.872, Nagelkerke R2¼0.384, po0.008) (95% CIs 1.011–
1.207). However, none of the TAS-20 subscales alone or combined
achieved a signiﬁcant contribution to any regression equation.
With TAS-20 as discrimination variable and DPD diagnosis as
classiﬁer, the area under the ROC curve¼0.815, asymptotic
po0.016 (95% CIs 0.621–1.009). Therefore, both ROC analyses
successfully refuted the null hypothesis of 0.5 in areal classiﬁca-
tion, and demonstrated sufﬁcient speciﬁcity for the clinical diag-
nosis. In summary, it can be stated that although TAS-20 score is
also a signiﬁcant predictor of the clinical DPD diagnosis, the CDS
retains a much higher unique variance explanation expressed as R2
in the regression equation for the depersonalization diagnosis.3.5. fMRI correlation images with TAS and difference regions
for regression slopes
To further investigate the emotion-regulatory brain activation
pattern exhibited by DPD, we examined, using hypothesis driven
analyses, the relationships between neural and behavioral res-
ponse to emotional stimuli in DPD and NC. The detailed results are
presented in Supplemental Tables 1–4. To identify those regions, in
which the NC and DPD groups signiﬁcantly differ, we computed
for each emotion and TAS subscale differential regression images
(happy facial expressions, Table 2; sad emotional stimuli, Table 3);
DPD and NC groups differed signiﬁcantly in the following regions:
For total TAS-20 score, right globus pallidus externus (Fig. 2, Panel
A), and left dorsal ACC (BA 24) (Fig. 2, Panel B).Table 2
Comparison of regression slopes depersonalization disorder4normal control
subjects in happy expression intensities Alexithymia and composite taxons.
Region Hemisphere BA Mass X Y Z p-Value
TAS-20 Alexithymia level
Nucleus globus pallidus L 492.0 −14 4 4 0.0255
F1 Difﬁculty Identifying Feelings
Anterior insula R 492.0 36 4 −7 0.0346
F2 Difﬁculty describing feelings
Dorsal anterior cingulate L 24 590.4 −10 18 20 0.0174
F3 Externally oriented thinking
Paracingulate gyrus L 32 590.4 −10 48 4 0.0104
Note: Mass volume in mm3, BA Brodmann area, XYZ Talairach coordinates, p-value
tested against 50 random permutations.
Fig. 2. Visualization of the main differential regions for alexithymia severity.
Note:— Neurological convention. Panel A, left globus pallidus externus, differential
region for happy facial expression. Panel B, left dorsal anterior cingulate (BA 24),
differential region for sad facial expression of emotion.3.6. Groupwise signal levels and functional connectivity
The differential main clusters exhibiting the most signiﬁcant group
differences for the TAS-20 and its subscales were tested for functional
connectivity (signal levels in Fig. 3A and B). We used the signal levels
from these regions, in which the two groups most signiﬁcantly differ
in one alexithymia trait, to test for functional connectivity in terms of
their inter-correlations (non-parametric exact point-probabilites were
used to determine signiﬁcances to compensate for small N): Happy
Fig. 3. (A) BOLD signal levels from differential regions in happy condition. (B) BOLD signal levels from differential regions in sad condition.
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po0.0001), TAS-20 & F3 (r¼0.981; po0.0001), F1 & F2 (r¼0.919;
po0.0001), F1 & F3 (r¼0.851; po0.0001), F2 & F3 (r¼0.995;
po0.0001); sad NC: TAS-20 & F1 (r¼0.608; po0.001), TAS-20 & F2
(r¼0.339; po0.0001), TAS-20 & F3 (r¼0.343; po0.0001), F1 & F2
(r¼0.533; po0.0001), F1 & F3 (r¼0.239; ns), F2 & F3 (r¼0.347;
po0.0001); happy DPD: TAS-20 & F1 (r¼0.163; ns), TAS-20 & F2
(r¼0.245; ns), TAS-20 & F3 (r¼0.267; ns), F1 & F2 (r¼0.617;
po0.0001), F1 & F3 (r¼0.404; po0.0001), F2 & F3 (r¼0.775;
po0.0001); sad DPD: TAS-20 & F1 (r¼0.564; po0.0001), TAS-20 &
F2 (r¼0.513; po0.0001), TAS-20 & F3 (r¼0.234; ns), F1 & F2
(r¼0.269; ns), F1 & F3 (r¼0.091; ns), F2 & F3 (r¼0.662; po0.0001).
The indication\s for functional connectivity is that the numbers of
signiﬁcant paths for NC are 6 and 5; signiﬁcant paths for DPD 3 and 3
(happy and sad, respectively). It can therefore be stated that, under
emotional stimulation, DPD show reduced connectivity among regions
discriminating them from healthy controls with regard to different
alexithymia traits.4. Discussion
The present study tested the assumption that the alexithymia
trait contributes to the clinical diagnosis of DPD, and also sharescerebral mechanisms of emotion dysregulation with DPD. In the
current study, we correlated neural responses during processing
of three intensities of facial expressions of happy and sad
emotion with self-reported alexithymia level, as well as with
its three factor-analytic dimensions. In a novel statistical
approach, we computed the regression slopes between clinical
scales and BOLD responses and compared these between the DPD
group and a matched healthy control group. We then identiﬁed
brain regions with signiﬁcant differences in regression slopes
between the two groups. Functional connectivity was investi-
gated for the differential regions in each of the two groups.
Behaviorally, we were able to support the hypothesis that
alexithymia severity contributes substantially to the clinical diag-
nosis of DPD. The DPD group investigated in this study comprised
mainly mid-to-high-alexithymic individuals. The analyses that we
present reveal that alexithymia predicts DPD and uniquely
explains 38% in the variance of diagnoses made by expert
clinicians. Regarding abnormal processing of emotion in DPD, the
regions indicating signiﬁcant differences in alexithymia severity
for happy emotion were the left globus pallidus externus, and the
left dorsal anterior cingulate (BA 24) for sad emotion. The
ascertained brain regions with altered responses in alexithymia
are consistent with our hypotheses (i) to (vi), i.e. with the notion
that they are associated with interoception, monitoring and
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studies. Overall, the pattern of changes that we observe is very
similar to the “alexithymia regions” described for emotional
memory tasks in PTSD patients, perhaps owing to earlier ﬁndings
of a traumatogenic origin of DPD (Frewen et al., 2006, 2008;
Simeon et al., 2009). Moving to our prediction of co-involvement
of affective regions of the pain neuromatrix (hypothesis v), we
observed insular and ACC involvement, but not that of other regions
of the pain matrix. For the three facets of alexithymia (hypothesis
vi), as reﬂected by its subscales F1–F3, we can state that our ﬁndings
of anterior insula, ACC, and orbital gyrus support the assumption of
greatest group differences in interoceptive regions, and regions
involved in emotion regulation. Regarding hypothesis (vii), we
observed non-interoceptive regions in the DPD patients, supporting
the assumption of alternate regions engaged in emotion processing
—possibly explaining “emotional numbing”.
It is, however, important to note that the identiﬁed regions may
not only reﬂect abnormal emotional introspection, but may also be
related to reduced face-scanning abilities that have been shown to be
associated with higher alexithymia severity (Bird et al., 2011). It is
these peculiarities that may perhaps best explain why structures such
as the globus pallidus emerged as central regions of differences in face
processing. For happy and sad emotion intensities, the differentially
responding regions for the subscale Identiﬁcation of Feelings (TAS-20
F1) were anterior insula, left and right, respectively. The subscale
Description of Feelings (TAS-20 F2) had signiﬁcant slope differences in
left anterior (BA 24) and left posterior (BA 31) cingulate gyrus,
respectively. The regions showing group differences in BOLD/scale
regression slopes for the subscale “Externally Oriented Concrete
Thinking” (TAS-20 F3) were left paracingulate (BA 32) and right orbital
gyrus (BA 10), respectively. We will brieﬂy discuss these regions with
regard to recent ﬁndings.
Globus pallidus activation is frequently seen in anger and disgust
processing (Mataix-Cols et al., 2008), and lesions to it may cause DPD-
like symptoms such as social withdrawal, anhedonia, an inability to
feel, emotional blunting, emotional amnesia, and dementia-like inat-
tention (Vijayaraghavan et al., 2008). Considering DPD, the globus
pallidus has also been found to be involved in the cognitive generation
of affect, and supporting trait anxiety intensity (Malhi et al., 2004).
The ventral sector of the paracingulate gyrus is a region devoted to
facial memory and affective other-person knowledge (Todorov et al.,
2007). Previous studies have indicated its function in the assessment
of social reward from personal interaction (Walter et al., 2005), and in
other-related emotion reﬂection (Berthoz et al., 2002). PCC regions
have long been associated with interoceptive processing and social
cognition, more recently, as part of the self-related default-mode
network, and for decision-making (Immordino-Yang et al., 2009; von
dem Hagen et al., 2009; Andrews-Hanna et al., 2010). The anterior
insula, which is also commonly found to be activated during visual
emotion processing (Fusar-Poli et al., 2010), is part of the pain
neuromatrix, devoted to homeostatic control, bodily risk assessment,
and part of the defense system (Mobbs et al., 2009; Xue et al., 2010).
The orbital gyrus (BA 10), a key region in emotional intensity
regulation, is active during processing of happy and sad autobiographic
memories (Markowitsch et al., 2003). The regions indicating different
association levels between alexithymia scores and BOLD found in our
experiments encompass several regions involved in interoceptionwith
an emphasis on emotional reﬂection, as one key characteristic of
alexithymia (Berthoz et al., 2002).
The limitation of the present study lies in the relatively small
sample size owing to the comparative rarity of DPD as a primary
diagnosis. While we have no reason to suspect statistical bias due
to co-morbidity, some confounding by possible medication effects
in three patients cannot be excluded completely. Another limita-
tion is that we had not administered an affect scale as an
additional self-report control measure.Our study represents the ﬁrst investigation of alexithymia brain
mechanisms in DPD. In terms of future work, it is of interest that the
regions differentiating the DPD from NC reported here resemble
regions described in activations found in PTSD sufferers. A fruitful
approach would therefore be to carry out respective clinical group
comparisons. Further possible research directions would consist of
experimental investigations of deliberate emotion suppression and/or
modiﬁcation, internal sensations and/or pain processing of DPD
patients, to further establish abnormal mechanisms in this condition.Role of the funding source
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